Drugs / Viroflu
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02014168 Background | Jan → Apr 2014 | influenza | University of Oxford | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Viroflu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02014168 ↗ |
| Known as | Inflexal V | “One of these vaccines will be the seasonal influenza vaccine 'Viroflu' ('Inflexal V').” NCT02014168 ↗ |
| Modality | Vaccine | “One of these vaccines will be the seasonal influenza vaccine 'Viroflu' ('Inflexal V').” NCT02014168 ↗ |
| Route | Intramuscular | “1 dose (0.5ml) of Viroflu® and 1 dose of 1.5 x10\^8 pfu MVA-NP+M1 intramuscularly into the vastus lateralis muscle on day 0.” NCT02014168 ↗ |